FFO
ROIV icon

Fortitude Family Office’s Roivant Sciences ROIV Stock Holding History

Fortitude Family Office’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.98K Buy
282
+42
+18% +$1.24K ﹤0.01% 772
2026
Q1 		$6.65K Buy
240
+137
+133% +$3.52K ﹤0.01% 814
2025
Q4 		$2.23K Buy
103
+58
+129% +$1.14K ﹤0.01% 1129
2025
Q3 		$681 Buy
+45
New +$557 ﹤0.01% 1693

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fortitude Family Office's ROIV Position: Q2 2026 in Review

Fortitude Family Office increased its Roivant Sciences (ROIV) stake by 18% in Q2 2026, buying an estimated $1.24K and bringing the position to 282 shares worth $9.98K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Fortitude Family Office first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Fortitude Family Office held 282 shares of Roivant Sciences worth $9.98K as of Q2 2026.
  • Fortitude Family Office bought 42 Roivant Sciences shares in Q2 2026, an estimated $1.24K.
  • Roivant Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #772 holding.
  • Fortitude Family Office first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.